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THE FALSE CLAIMS ACT AS FAIL-SAFE IN A
DEREGULATED ENVIRONMENT
Renée Brooker *
Eva Gunasekera **
I.

THE FALSE CLAIMS ACT IS A FAIL SAFE FOR ATTACKING
THE OPIOID CRISIS

The Department of Justice has shined a large spotlight on the opioid crisis.
Earlier this year, Attorney General Jeff Sessions told a Senate subcommittee that
the Justice Department is “going after drug companies, doctors and pharmacists”
who are fueling the nation’s opioid epidemic. 1 As the opioid epidemic continues
to devastate communities and families across the nation, the Justice Department
is responding with innovative and appropriately aggressive approaches and
using the full panoply of its enforcement tools. These have included increased
staffing, data analytics, new initiatives—sophisticated measures and tried-andtrue policing efforts. 2
*

Renée Brooker is the former Assistant Director for Civil Frauds at the Justice Department.
Eva Gunasekera is the former Senior Counsel for Health Care Fraud at the Justice Department.
The authors are former Department of Justice officials who prosecuted the False Claims Act and now
represent whistleblowers in False Claims Act cases at the Washington, D.C. offices of Finch McCranie LLP.
1
OPENING STATEMENT OF ATTORNEY GENERAL JEFF SESSIONS BEFORE THE SENATE APPROPRIATIONS
SUBCOMM. ON COMMERCE, JUSTICE, SCIENCE, AND RELATED AGENCIES, https://www.justice.gov/opa/speech/
opening-statement-attorney-general-jeff-sessions-senate-appropriations-subcommittee (last visited Nov. 16,
2018).
2
The Department of Justice’s efforts have included:
•
Attorney General Sessions announced on February 27, 2018, the launch of the Department of
Justice Prescription Interdiction and Litigation (PIL) Task Force to fight the prescription
opioid crisis. Through the PIL, the focus is on opioid manufacturers, pharmacies, pain
management clinics, drug testing facilities, and individual physicians
•
Attorney General Sessions emphasized the importance of using criminal and civil actions to
deter misconduct. Press Release, Attorney General Sessions Announces New Prescription
Interdiction & Litigation Task Force (Feb. 27, 2018) (on file with Dep’t of Justice).
•
Attorney General Sessions announced on April 3, 2018, the results of the first coordinated
action by the new Joint Criminal Opioid Darknet Enforcement (J-CODE) team in combatting
opioid trafficking by “disrupting the sale of drugs via the Darknet and dismantling criminal
enterprises that facilitate this trafficking.” Press Release, Attorney General Jeff Sessions
Announces Result of J-Code’s First Law Enforcement Operation Targeting Opioid Trafficking
on the Darknet (Apr. 3, 2018) (on file with Dep’t of Justice).
•
The Department of Justice joined a wave of state and municipal lawsuits spearheaded by the
Ohio Attorney General’s office alleging that opioid manufacturers and distributors used false,
deceptive, and misleading marketing to promote opioid painkillers. Katie Benner & Jan
Hoffman, Justice Dept. Backs High-Stakes Lawsuit Against Opioid Makers, N.Y. TIMES, Feb.
27, 2018, available at https://www.nytimes.com/2018/02/27/us/politics/justice-departmentopioid-lawsuit.html.
**
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But, let’s face it—the Justice Department cannot battle this epidemic alone.
As the Attorney General observed, “With one American dying of a drug
overdose every nine minutes, we need all hands on deck.” 3 The Department has
much on its plate right now from terrorism to corporate fraud to cyber security.
Exploiters of the drug crisis extend beyond pharmaceutical companies and
their executives who pay doctors to prescribe opioids for unintended uses. There
are others who bear responsibility for the crisis—individuals and companies that
have criminal and civil culpability. These include doctors who put patients at
risk because they are paid handsomely by the pharmaceutical industry to
prescribe opioids; laboratories churning out test results that put maximizing
billing ahead of patient safety; rehabilitation clinics that admit and discharge
addicted patients through a revolving door rather than providing effective
treatment options; drug insurance plans that cover opioids with no prior
permission required; and pharmacy benefits managers—the middlemen—that
make access to opioids easier than less addictive alternative remedies. Holding
these providers and companies accountable requires that knowledgeable insiders
come forward. There are anti-retaliation laws to protect whistleblowers who
provide tips and helpful information to the government.
This country needs ordinary Americans to step forward and step up—
individuals who will “do the right thing.” Effective enforcement of our nation’s
laws to solve the opioid crisis is dependent upon help from individuals with firsthand knowledge of the harmful practices that have brought us to the regrettable
circumstances we find ourselves in today. The False Claims Act—the Justice
Department’s primary civil enforcement tool—provides financial rewards to
whistleblowers. It is a legitimate enforcement tool to augment the efforts of the
Justice Department. Insiders with personal knowledge of abusive practices that
put patients at risk and waste taxpayer dollars can make an enormous difference.
Historically, insiders have been responsible for exposing some of this
country’s most harmful health care practices—prompting legislative reforms,
increasing funding for preventative and enforcement initiatives, and leading to
improvements in compliance practices of the health care industry. With the help
of insiders, attention and publicity to this issue could prompt the following
additional actions and much more:

3
Press Release, Attorney General Sessions Announces Director of Opioid Entertainment and Prevention
Efforts (Dec. 20, 2017) (on file with Dep’t of Justice).
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• Legislative efforts
o

o

o

o

Increasing the funding for preventative and enforcement efforts
launched by the Department of Justice, executive branch agencies,
the states and municipalities.
Increase the funding for treatment options such as drug
rehabilitation and detoxification services, including for individuals
without insurance coverage.
Revisiting compliance measures for financial institutions to ensure
they are not recklessly or negligently funding and sustaining the
opioid epidemic.
Limiting the marketing and availability of opioids and other
addictive drugs through strengthened oversight and regulation of
the pharmaceutical companies that manufacture and distribute the
drugs.

• Improved physician-patient practices
o

o
o

Ensuring that knowledge and education about substance abuse
prevention, detection, and treatment are clinical requirements for
physicians, particularly primary care practitioners.
Imposing mandates to limit the quantities of prescriptions for
opioids and other addictive drugs.
Emphasizing the importance of sustained treatment to avoid relapse
and overdoses.

The economic effects of this crisis are widespread and sizeable. The Council
of Economic Advisers released a report finding that the economic cost of the
crisis was over $504 billion in 2015, largely stemming from health care costs
but also including foregone employment earnings, lost productivity, and
increased criminal justice costs. Because the mortality rate of this epidemic is
most acute for Americans 50 years and younger, the economic impact is even
more substantial than other health related epidemics: 4
In April 2018, the Department of Health and Human Services reported a
joint-focus with the Justice Department on those who have played a role in the
opioid crisis. 5
4

THE COUNCIL OF ECON. ADVISERS, THE UNDERESTIMATED COST OF THE OPIOID CRISIS (2017).
The Department of Health and Human Services and the Department of Justice Health Care Fraud and
Abuse Control Program Annual Report for Fiscal Year 2017 2017 HCFAC program report issued on Friday
(April 6), THE DEP’T. OF HEALTH AND HUMAN SERVICES & THE DEP’T. OF JUSTICE, HEALTH CARE FRAUD AND
ABUSE CONTROL PROGRAM ANNUAL REP. FOR FISCAL YEAR 2017 (2017).
5
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•
•
•

II.

Too many trusted medical professionals like doctors, nurses and
pharmacists have chosen to violate their oaths and exploit this
generosity to line their pockets, sometimes for millions of dollars.
Pharmaceutical manufacturers have entered into Corporate Integrity
Agreements.
The Justice Department has formed the Opioid Fraud and Abuse
Detection Unit, a new pilot program that will use data to help prosecute
individuals and entities involved in illegal activities that fuel the crisis.
THE FALSE CLAIMS ACT IS A FORMIDABLE ENFORCEMENT TOOL

Consistently, the False Claims Act is the government’s most effective civil
tool to weed out fraud and return billions of dollars to taxpayer-funded
programs. 6 Recoveries under the False Claims Act have exceeded billions of
dollars annually and help preserve the integrity of vital government programs
that enable Americans to purchase homes, provide health care to older
Americans and low income families, and ensure our national security and
defense. Most industries in the United States are impacted by the False Claims
Act. Any company—whether publicly traded or privately-owned—that does
business either directly or indirectly with the Federal Government (and
numerous state governments) has potential exposure under the False Claims Act
and in certain sectors, such as the financial services sector, under the Financial
Institutions Reform, Recovery, and Enforcement Act of 1989 (FIRREA).
FIRREA provides civil penalties for certain kinds of fraud affecting a federallyinsured financial institution.
The False Claims Act is a federal law that imposes civil liability on
companies and individuals that defraud government-funded programs. It holds
a company liable to pay damages, plus three times the amount of damages that
the Federal Government sustains because of the false claim, as well as penalties.
The False Claims Act includes a qui tam provision that allows private
individuals (known as relators or whistleblowers) to file civil actions in the name
of the Federal Government and to recover a percentage of any settlement or
judgment under the Act. The media, which avidly reports False Claims Act
recoveries and judgments, calls them “whistleblower suits.” Whistleblowers are
6
Press Release, Justice Dep’t. Recovers Over $3.5 Billion From False Claims Act Cases in Fiscal Year
2015 (Dec. 3, 2015) (on file with Dep’t. of Justice); Press Release, Wells Fargo Bank Agrees to Pay $1.2 Billion
for Improper Mortgage Lending Practices (Apr. 8, 2016) (on file with Dep’t. of Justice); Press Release, Just.
Dep’t. Collects More Than $15.3 Billion In Civil and Criminal Cases in Fiscal Year 2016 (Dec. 14, 2016) (on
file with Dep’t. of Justice); Press Release, Just. Dep’t. Recovers nearly $ Billion from False Claims Act Cases
in Fiscal Year 2014 (Nov. 20, 2014) (on file with Dep’t. of Justice).
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key—and they largely dictate where the Justice Department’s priorities lie.
The Department’s use of the False Claims Act will continue unabated—as
history has shown, Presidential Administrations of either political party have
vigorously enforced the False Claims Act—and should help to attack the opioid
crisis from an enforcement perspective. The Act has always had considerable
support from Congress and, most notably, from Republican Senator Chuck
Grassley who has called the False Claims Act “hands down, the most effective
tool the government has to fight fraud against the taxpayers….the modern-day
False Claims Act is now 30 years old. It is the most successful piece of antifraud legislation in U.S. history, and it has always enjoyed strong bipartisan
support.” Further, as reported by the National Law Journal in June 2016, the
United States Supreme Court reinforced the broad scope and power of the False
Claims Act.
Other areas of steady and increasing focus of the Justice Department’s False
Claims Act enforcement practice include: health care fraud involving
pharmaceutical manufacturers, health care providers, hospitals, physicians,
physician practice groups, laboratories, managed care providers, pharmacies,
hospice and nursing home providers, and various government suppliers, many
of which may have a role in perpetuating drug addiction. In fact, any company
or institution receiving, or participating in, research grants, subsidy programs,
loan guarantee programs, federal building construction, government equipment
and information technology purchases, selling goods and services to the
military, and foreign aid, all fall within the purview of the False Claims Act.
Simply put—the False Claims Act materially affects how companies do
business.
III. THE FALSE CLAIMS ACT IS A REPEAT PERFORMER FOLLOWING
DE-REGULATION
The False Claims Act is a formidable and necessary enforcement tool to keep
participants in every industry that receive federal dollars (directly or indirectly)
in check. This is particularly so where there is actual or threatened deregulation
and a state of crisis like the one we are currently experiencing. We need not look
far in the past for similar examples of this. Ten years ago, we saw the collapse
of the financial industry beginning with the fall of the Lehman Brothers. 7
Wrongdoing in the mortgage industry helped lead to a devastating crisis that

7
James Mackintosh, Lehman’s Lessons, 10 Years Later, THE WALL STREET JOURNAL, Sept. 7, 2018,
available at https://www.wsj.com/articles/lehmans-lessons-10-years-later-1536255748.
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spanned the globe. We found ourselves in this position because of deregulation
coupled with many other factors that have been well-covered by scholars. In the
absence of sensible regulation, the Department of Justice used the False Claims
Act to correct the regulatory failures that the financial market itself did not
address.
By example, one important program of the United States Department of
Housing and Urban Development was at risk. In late 2012, HUD was facing the
near collapse of its Federal Housing Agency’s single family mortgage insurance
fund. Under the program, homebuyers obtained FHA-insured mortgages from
HUD-approved lenders to purchase homes with low down payments. By
insuring commercial lenders against loss, HUD encouraged lenders to invest
capital in the home mortgage market. The program was intended to help ordinary
Americans realize the dreams of homeownership.
Yet, for the first time in its 80 year history, the FHA was considering a
potential taxpayer bailout of a program that was insuring a portfolio of more
than $1 trillion in mortgages. In response, the Department of Justice took swift
action under an enforcement program called the “Big Lender Initiative.” Armed
with the False Claims Act, the Department of Justice investigated dozens of
lenders that participated in the FHA’s single family mortgage insurance
program. JPMorgan Chase was the first to get in line to repay the nearly
insolvent insurance fund and admit wrongdoing. SunTrust, U.S. Bank, Bank of
America, Wells Fargo, and many others followed. In this way, the False Claims
Act acted as a fail-safe after chaos reigned in a deregulated environment. It was
the Justice Department with its powerful enforcement tool that held the largest
mortgage lenders in the world responsible for years of reckless underwriting of
tens of thousands of bad loans that resulted in actual harm to real individuals.
Even as recently as fiscal year 2016, the Justice Department collected more than
$15.3 billion in civil and criminal cases, with the largest settlements from cases
still related to the effects of the financial crisis. 8
IV. THE FALSE CLAIMS ACT AS FAIL-SAFE
Make no mistake about it. The False Claims Act is needed to fight the opioid
crisis with the help of whistleblowers. While it may be a blunt tool compared to
sensible laws aimed at addressing the root causes of addiction, the False Claims
Act will once again act as a fail-safe. By some measure, it will address the

8
Press Release, Justice Dep’t. Collects More than $15.3 Billion in Civ. and Crim. Cases in Fiscal Year
2016 (Dec. 14, 2016) (on file with Dep’t. of Justice).
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terrible economic and health effects of opioids wrought by wrongdoers willing
to exploit others for financial gain—just as it was used effectively during the
financial crisis.

